1: Spencer PS, Palmer VS, Kisby GE. Cycad β-N-methylamino-L-alanine (BMAA), methylazoxymethanol, genotoxicity, and neurodegeneration. Toxicon. 2018 Dec 1;155:49-50. doi: 10.1016/j.toxicon.2018.10.005. Epub 2018 Oct 11. PMID: 30316979.
2: Dunlop RA, Guillemin GJ. The Cyanotoxin and Non-protein Amino Acid β-Methylamino-L-Alanine (L-BMAA) in the Food Chain: Incorporation into Proteins and Its Impact on Human Health. Neurotox Res. 2019 Oct;36(3):602-611. doi: 10.1007/s12640-019-00089-9. Epub 2019 Aug 3. PMID: 31377995.
3: Proctor EA, Mowrey DD, Dokholyan NV. β-Methylamino-L-alanine substitution of serine in SOD1 suggests a direct role in ALS etiology. PLoS Comput Biol. 2019 Jul 19;15(7):e1007225. doi: 10.1371/journal.pcbi.1007225. PMID: 31323035; PMCID: PMC6668853.
4: Rauk A. β- N-Methylamino-l-alanine (BMAA) Not Involved in Alzheimer's Disease. J Phys Chem B. 2018 Apr 26;122(16):4472-4480. doi: 10.1021/acs.jpcb.8b01641. Epub 2018 Apr 17. PMID: 29649877.
5: Violi JP, Facey JA, Mitrovic SM, Colville A, Rodgers KJ. Production of β-methylamino-L-alanine (BMAA) and Its Isomers by Freshwater Diatoms. Toxins (Basel). 2019 Sep 2;11(9):512. doi: 10.3390/toxins11090512. PMID: 31480725; PMCID: PMC6784237.
6: Okamoto S, Esumi S, Hamaguchi-Hamada K, Hamada S. β-N-methylamino-L-alanine (BMAA) suppresses cell cycle progression of non-neuronal cells. Sci Rep. 2018 Dec 20;8(1):17995. doi: 10.1038/s41598-018-36418-9. PMID: 30573743; PMCID: PMC6301973.
7: van Onselen R, Venables L, van de Venter M, Downing TG. β-N-Methylamino-L- Alanine Toxicity in PC12: Excitotoxicity vs. Misincorporation. Neurotox Res. 2018 Jan;33(1):15-23. doi: 10.1007/s12640-017-9743-8. Epub 2017 May 3. PMID: 28470567.
8: Han NC, Bullwinkle TJ, Loeb KF, Faull KF, Mohler K, Rinehart J, Ibba M. The mechanism of β-N-methylamino-l-alanine inhibition of tRNA aminoacylation and its impact on misincorporation. J Biol Chem. 2020 Jan 31;295(5):1402-1410. doi: 10.1074/jbc.RA119.011714. Epub 2019 Dec 20. PMID: 31862734; PMCID: PMC6996898.
9: Kokubo Y, Banack SA, Morimoto S, Murayama S, Togashi T, Metcalf JS, Cox PA, Kuzuhara S. β-N-methylamino-l-alanine analysis in the brains of patients with Kii ALS/PDC. Neurology. 2017 Sep 5;89(10):1091-1092. doi: 10.1212/WNL.0000000000004310. Epub 2017 Aug 9. PMID: 28794246.
10: Contardo-Jara V, Schwanemann T, Esterhuizen-Londt M, Pflugmacher S. Protein association of β-N-methylamino-L-alanine in Triticum aestivum via irrigation. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2018 Apr;35(4):731-739. doi: 10.1080/19440049.2018.1427283. Epub 2018 Jan 25. PMID: 29324084.
11: Bishop SL , Murch SJ . A systematic review of analytical methods for the detection and quantification of β-N-methylamino-l-alanine (BMAA). Analyst. 2019 Dec 16;145(1):13-28. doi: 10.1039/c9an01252d. PMID: 31742261.
12: Cheng F, Fransson LÅ, Mani K. The cyanobacterial neurotoxin β-N-methylamino- l-alanine prevents addition of heparan sulfate to glypican-1 and increases processing of amyloid precursor protein in dividing neuronal cells. Exp Cell Res. 2019 Jun 15;379(2):172-181. doi: 10.1016/j.yexcr.2019.03.041. Epub 2019 Apr 3. PMID: 30953622.
13: Regueiro J, Negreira N, Carreira-Casais A, Pérez-Lamela C, Simal-Gándara J. Dietary exposure and neurotoxicity of the environmental free and bound toxin β-N-methylamino-l-alanine. Food Res Int. 2017 Oct;100(Pt 1):1-13. doi: 10.1016/j.foodres.2017.07.033. Epub 2017 Jul 20. PMID: 28873667.
14: Meneely JP, Chevallier OP, Graham S, Greer B, Green BD, Elliott CT. β-methylamino-L-alanine (BMAA) is not found in the brains of patients with confirmed Alzheimer's disease. Sci Rep. 2016 Nov 8;6:36363. doi: 10.1038/srep36363. PMID: 27821863; PMCID: PMC5099567.
15: Delcourt N, Claudepierre T, Maignien T, Arnich N, Mattei C. Cellular and Molecular Aspects of the β-N-Methylamino-l-alanine (BMAA) Mode of Action within the Neurodegenerative Pathway: Facts and Controversy. Toxins (Basel). 2017 Dec 22;10(1):6. doi: 10.3390/toxins10010006. PMID: 29271898; PMCID: PMC5793093.
16: Waidyanatha S, Ryan K, Sanders JM, McDonald JD, Wegerski CJ, Doyle-Eisle M, Garner CE. Disposition of β-N-methylamino-l-alanine (L-BMAA), a neurotoxin, in rodents following a single or repeated oral exposure. Toxicol Appl Pharmacol. 2018 Jan 15;339:151-160. doi: 10.1016/j.taap.2017.12.008. Epub 2017 Dec 15. PMID: 29248465.
17: Popova AA, Koksharova OA. Neurotoxic Non-proteinogenic Amino Acid β-N- Methylamino-L-alanine and Its Role in Biological Systems. Biochemistry (Mosc). 2016 Aug;81(8):794-805. doi: 10.1134/S0006297916080022. PMID: 27677549.
18: Yan B, Liu Z, Huang R, Xu Y, Liu D, Wang W, Zhao Z, Cui F, Shi W. Impact factors on the production of β-methylamino-L-alanine (BMAA) by cyanobacteria. Chemosphere. 2020 Mar;243:125355. doi: 10.1016/j.chemosphere.2019.125355. Epub 2019 Nov 14. PMID: 31759214.
19: Scott LL, Downing TG. Β-N-Methylamino-L-Alanine (BMAA) Toxicity Is Gender and Exposure-Age Dependent in Rats. Toxins (Basel). 2017 Dec 27;10(1):16. doi: 10.3390/toxins10010016. PMID: 29280981; PMCID: PMC5793103.
20: Downing S, Van Onselen R, Kemp G, Downing TG. Metabolism of the neurotoxic amino acid β-N-methylamino-L-alanine in human cell culture models. Toxicon. 2019 Oct;168:131-139. doi: 10.1016/j.toxicon.2019.07.007. Epub 2019 Jul 19. PMID: 31330193.